Vascular Access – an evidence-based approach – Page 13 – Focusing in on current clinical practices in the art and science of Vascular Access..

Page 13 of 19

July 30, 2017July 3, 2017

Vascular Access in Pediatric Patients in the Emergency Department: Types of Access, Indications, and Complications.

New article on review of pediatric vascular access in the Emergency Department from Pediatric Emergency Medicine Practice

Vascular Access in Pediatric Patients in the Emergency Department: Types of Access, Indications, and Complications.

July 27, 2017July 27, 2017

Nomogram predicted risk of peripherally inserted central catheter related thrombosis

New article on a risk nomogram to predict PICC-related thrombosis from Nature Scientific Reports (free OpenAccess)

Nomogram predicted risk of peripherally inserted central catheter related thrombosis

#vascularaccess #FOAMva #FOAMed #FOAMus #FOAMcc #FOAMems #FOAMrad

July 23, 2017July 3, 2017

Beware: The femoral haemodialysis catheter – a surgeon’s perspective.

New article on the femoral hemodialysis catheter from a surgical perspective from the South African Medical Journal

Beware: The femoral haemodialysis catheter – a surgeon’s perspective

July 21, 2017June 29, 2017

A comparison of longitudinal and transverse approaches to ultrasound-guided axillary vein cannulation by experienced operators

New article on comparisons of longitudinal and transverse approaches to axillary vein cannulation under ultrasound from Journal of Thoracic Disease

A comparison of longitudinal and transverse approaches to ultrasound-guided axillary vein cannulation by experienced operators

July 18, 2017June 30, 2017

Vascular Access in the Elderly: Does One Size Fit All?

New article on vascular access in the elderly from American Journal of Nephrology

Vascular Access in the Elderly: Does One Size Fit All?

July 16, 2017July 3, 2017

The Scottish enhanced Staphylococcus aureus bacteraemia surveillance program: The first 18 months data in adults

New article on a Staph aureus surveillance program from Scotland from the Journal of Hospital Infection

The Scottish enhanced Staphylococcus aureus bacteraemia surveillance program: The first 18 months data in adults

Improving IV site visibility and accomplishing IV complication reduction April 19, 2018
This project aims to improve the visibility of the IV site using more adhesive transparent dressings to attain 90% compliance based on the frequent and proper inspection of the IV site and decrease the incidence of IV complications” Lim et al (2018). Abstract: Purpose: This project aims to improve the visibility of the IV site [...]
IVTEAM
Ethanol lock therapy treatment for biofilm-associated CLABSI April 19, 2018
According to our in vitro data, an ethanol-based lock solution with 40% ethanol + 60 IU heparin administered daily for 72 hours is sufficient to almost eradicate the metabolic activity of bacterial and fungal biofilms” Alonso et al (2018). Summary: Ethanol-based lock therapy (LT) solutions are used as an alternative to antibiotics for the conservative [...] […]
IVTEAM
Assessing patient risk of central line-associated bacteremia via machine learning April 19, 2018
Machine learning can be used to develop accurate models to predict the risk of CLABSI in real time prior to the development of infection” Beeler et al (2018). Abstract: Background: Central line-associated bloodstream infections (CLABSIs) contribute to increased morbidity, length of hospital stay, and cost. Despite progress in understanding the risk factors, […]
IVTEAM
Is chlorhexidine required for needleless connector decontamination? April 19, 2018
Unfortunately, intermittent reports from facilities have shown an increase in bloodstream infections (BSIs) thought to be associated with NC use” Flynn et al (2018). Abstract: Since the introduction in the early 1990s of a needleless connector (NC) on vascular access devices to minimize the risk of needle stick injuries to healthcare workers, their use is [. […]
IVTEAM
Chlorhexidine-containing dressings in the prevention of CLABSI April 19, 2018
Our study shows similar results in overall direct treatment costs, meaning that higher acquisition costs of chlorhexidine-containing dressings did not translate into higher costs. Expenses were primarily outweighed by a lower rate of probable/definite CRBSI and reduced associated costs” Heimann et al (2018). Reference: Background: A recent study reported a r […]
IVTEAM

Page 13 of 19

Share this:

Like this:

Share this:

Like this:

Share this:

Like this:

Share this:

Like this:

Share this:

Like this:

Share this:

Like this: